| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
5 |
/ |
2020 |
|
|
|
| |
Data sporządzenia: |
2020-02-05 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Abstract acceptance of CompuFlo Epidural Instrument integrated with CompuWave for
presentation at the Euroanaesthesia 2020 Congress
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, “the Company", “the Issuer"_,
today announced that an abstract, entitled "Confirmation of epidural catheter location
by epidural pressure waveform recordings by the CompuFlo® Epidural Instrument _CompuFlo_,"
has been accepted for presentation at the prestigious Euroanaesthesia 2020 Congress
taking place May 30 - June 1, 2020 in Barcelona, Spain. Euroanaesthesia is Europe’s
largest annual event showcasing the latest news and innovations in the field of anesthesia,
perioperative medicine, intensive care, emergency medicine and pain treatment. This
international event gathers upwards of six thousand delegates from around the world.The
abstract will be presented during scientific poster sessions highlighting how CompuWave
technology integrated with the CompuFlo Epidural System combines both objective in-line
pressure measurements and the detection of a pulsatile pressure waveform in a single
system.
The CompuFlo-CompuWave system can be used to aid in the instant identification of
a needle or catheter within an anatomic structure such as the epidural space. Under
current standard of care, the epidural procedure involves the anesthesiologist giving
a bolus injection of medication and waiting 20-40 minutes to see if the patient gets
pain relief or if the catheter has been dislodged and needs to be reinserted. This
is the first integrated system of its kind to detect both the in-situ pressure and
the presence of a pulsatile pressure waveform _detection of pressures that are produced
by the cardio-vascular system either directly or indirectly_ to determine within seconds
if the needle and catheter are in the right position. This ability can save time
and cost during a procedure, which is a benefit to the patient, physician and the
institution.
The abstract was authored by Dr. Giorgio Capogna, MD, Head of the Department of Anesthesiology
at Città di Roma Hospital in Rome, Professor of Obstetric Anesthesia at the University
of Rome, Director of the European School of Obstetric Anesthesia and Maternal Neonatale
Simulation Centre in Rome. Dr. Capogna is also a member of Scientific Advisory Board
of Milestone Scientific, the majority shareholder and licensor of the Issuer. The
abstract will be published in the supplement of the European Journal of Anaesthesiology
that will coincide with the meeting.
The Board of Directors of the Company believes that the study summarized in the abstract
is further validation of the ability of CompuFlo Epidural System integrated with CompuWave
technology to safely and effectively verify location of the needle or catheter in
the epidural space. The CompuFlo-CompuWave Epidural System has the potential to transform
the administration of epidural procedures by confirming the status of a catheter in
real time as opposed to catheter placement assessed by a subjective patient response
to medication, which may take 20 to 40 minutes. The unique computer-controlled real-time
pressure sensing technology combined with pulsatile pressure waveform technology provides
anesthesiologists with an objective, fast and quantifiable technique to build confidence
and success in epidural placement.
The Board of Directors of the Issuer is honored to have the technology featured by
a leading anesthesiologist at the premier industry conference in Europe in front of
world leaders in the field of anesthesia. The adoption of CompuFlo integrated with
the new CompuWave technology is poised to accelerate in Europe as more anesthesia
providers learn that CompuFlo Epidural Instrument offers a proven alternative to the
loss of resistance syringe and provides a more reliable way to identify the epidural
space and verify that the catheter has not been displaced.
|
|
|
RB_ASO: Abstract acceptance of CompuFlo Epidural Instrument integrated with CompuWave for
presentation at the Euroanaesthesia 2020 Congress
